1. Effect of urban air pollution on CRP and coagulation: a study on inpatients with acute exacerbation of chronic obstructive pulmonary disease
   Lingling Tang et al, 2021, BMC Pulmonary Medicine CrossRef
2. Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials
   Mingjin Yang et al, 2020, Inflammopharmacology CrossRef
3. Pharmacological and clinical application of heparin progress: An essential drug for modern medicine
   Min Qiu et al, 2021, Biomedicine & Pharmacotherapy CrossRef
4. COPD and Anticoagulation Therapy: Time for a New Approach?
   Ovidiu Rusalim Petris et al, 2021, International Journal of Chronic Obstructive Pulmonary Disease CrossRef
5. Effects of oral anticoagulant therapy in patients with pulmonary diseases
   Jiying Lai et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
6. The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease
   Ümmügülsüm Can et al, 2014, Journal of Investigative Medicine CrossRef
7. Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure – A danish nationwide registry-based study
   Charlotte Andersson et al, 2019, European Journal of Internal Medicine CrossRef
8. The Changes and Their Clinical Significance of Serum High-Sensitivity C-Reactive Protein (hs-CRP) and Plasma Fibrinogen (Fib) in COPD Patients
   红莉 武, 2017, Advances in Clinical Medicine CrossRef
9. Optimal choice of pharmacological therapy – Prevention of stroke and assessment of bleeding risk in patients with atrial fibrillation
   Izet Masic et al, 2019, International Journal of Preventive Medicine CrossRef
10. Strategies for sustained release of heparin: A review
    Xuewen Yang et al, 2022, Carbohydrate Polymers CrossRef
11. Heparin: 100 years of pleiotropic effects
    Adilson Ferraz Paschoa, 2016, Journal of Thrombosis and Thrombolysis CrossRef
12. Aspects extrapulmonaires des exacerbations de bronchopneumopathie chronique obstructive
    D. Viglino et al, 2020, Annales françaises de médecine d’urgence CrossRef
13. Heparin beyond anti-coagulation
    Daohong Chen, 2021, Current Research in Translational Medicine CrossRef
14. [Retracted] Study on the Relationship between AAD and Clinical Features in Emergency Ward Patients and the Application Effect of Probiotics
    Wenjuan Qiu et al, 2022, Contrast Media & Molecular Imaging CrossRef
15. TWO CASES OF TYPE II RESPIRATORY FAILURE IN COPD TREATED IN KATURI MEDICAL COLLEGE HOSPITAL, GUNTUR AND AN OVERVIEW OF TREATMENT OF ACUTE EXACERBATION AND RESPIRATORY FAILURE
    Ramakrishna R et al, 2015, Journal of Evidence Based Medicine and Healthcare CrossRef
16. Optimal time to use low molecular weight heparin on prethrombotic state of rat chronic obstructive pulmonary disease model
    Wang Yanqing et al, 2014, Chinese Medical Journal CrossRef
17. Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial
    Tarek Mohamed Ashoor et al, 2020, Korean Journal of Anesthesiology CrossRef
18. Efficacy of Low Molecular Weight Heparin in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Ventilatory Support
    Yongbing Qian et al, 2014, COPD: Journal of Chronic Obstructive Pulmonary Disease CrossRef